Skip to main content
Clinical Trials/NCT03953365
NCT03953365
Unknown
Not Applicable

Prevention of Incisional Hernia With Prophylactic Mesh in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. A Multicentre, Prospective, Randomised Controlled Trial

Hospital Universitario Fundación Alcorcón0 sites66 target enrollmentJune 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Incisional Hernia
Sponsor
Hospital Universitario Fundación Alcorcón
Enrollment
66
Primary Endpoint
Rate of Incisional Hernia
Last Updated
6 years ago

Overview

Brief Summary

Evaluate the effectiveness of mesh reinforcement in high-risk patients to prevent incisional hernia.

Detailed Description

Based on the hypothesis that oncological cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC) is associated with an increased risk of developing Incisional Hernia in the postoperative period, with an expected incidence of 50% at 24 months, we designed a prospective, multicenter and randomized clinical study to demonstrate the utility of the meshes in the prevention of Incisional Hernia, hoping to reduce the incidence to 15% at 24 months.

Registry
clinicaltrials.gov
Start Date
June 1, 2019
End Date
December 31, 2023
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Hospital Universitario Fundación Alcorcón
Responsible Party
Principal Investigator
Principal Investigator

Federico Ochando

MEDICAL DOCTOR

Hospital Universitario Fundación Alcorcón

Eligibility Criteria

Inclusion Criteria

  • Completeness of cytoreduction after surgery (CC-SCORE) CC-0, CC-1

Exclusion Criteria

  • Completeness of cytoreduction after surgery (CC-SCORE) CC-2, CC-3

Outcomes

Primary Outcomes

Rate of Incisional Hernia

Time Frame: four years

Prevention of Incisional Hernia

Similar Trials